FSD Pharma Inc. | WebDisclosure

Basculer en Français

8295	Companies
114863	Keywords
55304	Articles
62446	Press releases

Home
Companies
FSD Pharma Inc.

BRIEF

published on 08/09/2024 at 13:35, 3 months 11 days ago

FSD Pharma fait le point sur le lancement et le financement de Celly Nutrition

FSD Pharma Métabolisme De L'alcool Sans Buzz Produits De Récupération Tour De Financement
BRIEF

published on 08/09/2024 at 13:35, 3 months 11 days ago

FSD Pharma Updates on Celly Nutrition's New Launch and Financing

FSD Pharma Alcohol Metabolism Financing Round Unbuzzd Recovery Products
PRESS RELEASE

published on 08/09/2024 at 13:30, 3 months 11 days ago

FSD Pharma Provides Update on its Investment in Celly Nutrition Corp. Who Secures Additional Financing to Launch unbuzzd(TM) Stick Packs this Month - Created by a World-Class Pharmaceutical Research & Development Team
FSD Pharma's Celly Nutrition launches unbuzzd™, a new beverage aiding alcohol metabolism. Featuring innovative stick packs, it supports faster recovery and enhanced cognition

FSD Pharma Recovery Unbuzzd™ Alcohol Metabolism Celly Nutrition
BRIEF

published on 06/28/2024 at 23:05, 4 months 22 days ago

FSD Pharma Engages Totaligent for Market Awareness Campaign

FSD Pharma Biopharmaceutical Corporate Update Totaligent Market Awareness
BRIEF

published on 06/28/2024 at 23:05, 4 months 22 days ago

FSD Pharma engage Totaligent pour une campagne de sensibilisation au marché

Biopharmaceutique FSD Pharma Mise À Jour De L'entreprise Totaligent Conscience Du Marché
PRESS RELEASE

published on 06/28/2024 at 23:00, 4 months 22 days ago

FSD Pharma provides Corporate Update
FSD Pharma Inc. announces engagement of Totaligent Inc. for market awareness and shareholder engagement. Totaligent contracted for promotional activities with a 30-day term

FSD Pharma Inc. Shareholder Engagement Market Awareness Totaligent Inc. Promotional Activities
BRIEF

published on 06/28/2024 at 13:35, 4 months 22 days ago

FSD Pharma Inc. Wins Final Judgment Against Dr. Raza Bokhari

FSD Pharma Legal Ruling Dr. Raza Bokhari Final Judgment Arbitration Award
BRIEF

published on 06/28/2024 at 13:35, 4 months 22 days ago

FSD Pharma Inc. remporte le jugement final contre le Dr Raza Bokhari

FSD Pharma Dr Raza Bokhari Jugement Définitif Récompense D'arbitrage Décision Juridique
PRESS RELEASE

published on 06/28/2024 at 13:30, 4 months 22 days ago

FSD Pharma, Inc. Wins Final Judgment to Confirm Arbitration Award of $3,059,998 Plus Interest Entered Against Dr. Raza Bokhari, Currently Serving as Chairman and CEO of Medicus Pharma Ltd.
FSD Pharma Inc. announces victory in legal battle against Dr. Raza Bokhari. Court judgment grants FSD Pharma damages and interest. Future plans detailed

Biopharmaceutical Company FSD Pharma Inc. Victory Legal Battle Court Judgment
BRIEF

published on 06/27/2024 at 13:35, 4 months 23 days ago

FSD Pharma reçoit l'approbation du comité d'éthique pour un essai clinique de phase 1 en Australie

FSD Pharma Sclérose En Plaques Essai Clinique Lucide-21-302 Approbation HREC

1 2 ... 9

Accesswire

Published on 11/21/2024 at 12:00, 43 minutes ago

Alset AI Announces Full Repayment of $3.7 Million Secured Loan with Interest from Portfolio Company, Significantly Strengthening Balance Sheet
Published on 11/21/2024 at 12:00, 43 minutes ago

Battery X Metals Commences Strategic Initiatives to Strengthen Balance Sheet
Published on 11/21/2024 at 11:30, 1 hour 13 minutes ago

FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 2 hours 40 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 2 hours 43 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 12:35, 7 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 28 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 36 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 42 minutes ago

Holding(s) in Company
Published on 11/21/2024 at 11:30, 1 hour 13 minutes ago

APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived

Les Echos

Published on 11/21/2024 at 06:58, 5 hours 45 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 45 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 45 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 16 hours 35 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 23 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE